222 related articles for article (PubMed ID: 22609489)
1. Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature.
Brunetti O; Imbrici P; Botti FM; Pettorossi VE; D'Adamo MC; Valentino M; Zammit C; Mora M; Gibertini S; Di Giovanni G; Muscat R; Pessia M
Neurobiol Dis; 2012 Sep; 47(3):310-21. PubMed ID: 22609489
[TBL] [Abstract][Full Text] [Related]
2. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
Ishida S; Sakamoto Y; Nishio T; Baulac S; Kuwamura M; Ohno Y; Takizawa A; Kaneko S; Serikawa T; Mashimo T
Brain Res; 2012 Jan; 1435():154-66. PubMed ID: 22206926
[TBL] [Abstract][Full Text] [Related]
3. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
Imbrici P; D'Adamo MC; Kullmann DM; Pessia M
Eur J Neurosci; 2006 Dec; 24(11):3073-83. PubMed ID: 17156368
[TBL] [Abstract][Full Text] [Related]
4. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.
Imbrici P; Altamura C; Gualandi F; Mangiatordi GF; Neri M; De Maria G; Ferlini A; Padovani A; D'Adamo MC; Nicolotti O; Pessia M; Conte D; Filosto M; Desaphy JF
Mol Cell Neurosci; 2017 Sep; 83():6-12. PubMed ID: 28666963
[TBL] [Abstract][Full Text] [Related]
5. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
Imbrici P; Gualandi F; D'Adamo MC; Masieri MT; Cudia P; De Grandis D; Mannucci R; Nicoletti I; Tucker SJ; Ferlini A; Pessia M
Neuroscience; 2008 Dec; 157(3):577-87. PubMed ID: 18926884
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of episodic ataxia type-1.
Herson PS; Virk M; Rustay NR; Bond CT; Crabbe JC; Adelman JP; Maylie J
Nat Neurosci; 2003 Apr; 6(4):378-83. PubMed ID: 12612586
[TBL] [Abstract][Full Text] [Related]
7. Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing.
Ferrick-Kiddie EA; Rosenthal JJ; Ayers GD; Emeson RB
Sci Rep; 2017 Feb; 7():41095. PubMed ID: 28216637
[TBL] [Abstract][Full Text] [Related]
8. Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.
D'Adamo MC; Liantonio A; Rolland JF; Pessia M; Imbrici P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331416
[TBL] [Abstract][Full Text] [Related]
9. Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel alter hKvbeta 1-induced N-type inactivation.
Maylie B; Bissonnette E; Virk M; Adelman JP; Maylie JG
J Neurosci; 2002 Jun; 22(12):4786-93. PubMed ID: 12077175
[TBL] [Abstract][Full Text] [Related]
10. An activator of voltage-gated K
Servettini I; Talani G; Megaro A; Setzu MD; Biggio F; Briffa M; Guglielmi L; Savalli N; Binda F; Delicata F; Bru-Mercier G; Vassallo N; Maglione V; Cauchi RJ; Di Pardo A; Collu M; Imbrici P; Catacuzzeno L; D'Adamo MC; Olcese R; Pessia M
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2207978120. PubMed ID: 37487086
[TBL] [Abstract][Full Text] [Related]
11. Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.
Imbrici P; D'Adamo MC; Grottesi A; Biscarini A; Pessia M
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1314-22. PubMed ID: 21307345
[TBL] [Abstract][Full Text] [Related]
12. Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.
Yuan H; Yuan H; Wang Q; Ye W; Yao R; Xu W; Liu Y
Mol Genet Genomic Med; 2020 Oct; 8(10):e1434. PubMed ID: 32705822
[TBL] [Abstract][Full Text] [Related]
13. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
Tomlinson SE; Rajakulendran S; Tan SV; Graves TD; Bamiou DE; Labrum RW; Burke D; Sue CM; Giunti P; Schorge S; Kullmann DM; Hanna MG
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1107-12. PubMed ID: 23349320
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.
Tristán-Clavijo E; Scholl FG; Macaya A; Iglesias G; Rojas AM; Lucas M; Castellano A; Martinez-Mir A
Mov Disord; 2016 Nov; 31(11):1743-1748. PubMed ID: 27477325
[TBL] [Abstract][Full Text] [Related]
15. Kv1.1 channelopathy abolishes presynaptic spike width modulation by subthreshold somatic depolarization.
Vivekananda U; Novak P; Bello OD; Korchev YE; Krishnakumar SS; Volynski KE; Kullmann DM
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2395-2400. PubMed ID: 28193892
[TBL] [Abstract][Full Text] [Related]
16. The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.
Chen SH; Fu SJ; Huang JJ; Tang CY
Sci Rep; 2016 Jan; 6():19378. PubMed ID: 26778656
[TBL] [Abstract][Full Text] [Related]
17. Basket to Purkinje Cell Inhibitory Ephaptic Coupling Is Abolished in Episodic Ataxia Type 1.
Martin HGS; Kullmann DM
Cells; 2023 May; 12(10):. PubMed ID: 37408217
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.
Shook SJ; Mamsa H; Jen JC; Baloh RW; Zhou L
Muscle Nerve; 2008 Mar; 37(3):399-402. PubMed ID: 17912752
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
Chen H; von Hehn C; Kaczmarek LK; Ment LR; Pober BR; Hisama FM
Neurogenetics; 2007 Apr; 8(2):131-5. PubMed ID: 17136396
[TBL] [Abstract][Full Text] [Related]
20. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Graves TD; Cha YH; Hahn AF; Barohn R; Salajegheh MK; Griggs RC; Bundy BN; Jen JC; Baloh RW; Hanna MG;
Brain; 2014 Apr; 137(Pt 4):1009-18. PubMed ID: 24578548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]